SL
LMAT icon

Summitry LLC’s LeMaitre Vascular LMAT Stock Holding History

Summitry LLC’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$355K Buy
3,697
+54
+1% +$5.54K 0.01% 215
2026
Q1 		$398K Hold
3,643
– – 0.01% 164
2025
Q4 		$295K Buy
3,643
+552
+18% +$47.5K 0.01% 182
2025
Q3 		$270K Buy
3,091
+424
+16% +$37.9K 0.01% 164
2025
Q2 		$221K Buy
+2,667
New +$223K 0.01% 162

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Summitry LLC's LMAT Position: Q2 2026 in Review

Summitry LLC increased its LeMaitre Vascular (LMAT) stake by 1.5% in Q2 2026, buying an estimated $5.54K and bringing the position to 3,697 shares worth $355K. The position accounts for 0.01% of the portfolio, ranked #215.

Summitry LLC first reported a position in LMAT in Q2 2025 and has held it in 5 quarters since. The position peaked at $398K in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Summitry LLC held 3,697 shares of LeMaitre Vascular worth $355K as of Q2 2026.
  • Summitry LLC bought 54 LeMaitre Vascular shares in Q2 2026, an estimated $5.54K.
  • LeMaitre Vascular made up 0.01% of Summitry LLC's portfolio in Q2 2026, its #215 holding.
  • Summitry LLC first reported a position in LeMaitre Vascular in Q2 2025 and has held it in 5 quarters since.
  • Summitry LLC's LeMaitre Vascular position peaked at $398K in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Summitry LLC's 13F filing for Q2 2026, filed 21 Jul 2026.